{"id":"https://openalex.org/W2002134787","doi":"https://doi.org/10.1542/peds.2006-3695","title":"A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder","display_name":"A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder","publication_year":2007,"publication_date":"2007-12-31","ids":{"openalex":"https://openalex.org/W2002134787","doi":"https://doi.org/10.1542/peds.2006-3695","mag":"2002134787","pmid":"https://pubmed.ncbi.nlm.nih.gov/18166547"},"language":"en","primary_location":{"id":"doi:10.1542/peds.2006-3695","doi":"https://doi.org/10.1542/peds.2006-3695","is_oa":false,"landing_page_url":"https://doi.org/10.1542/peds.2006-3695","pdf_url":null,"source":{"id":"https://openalex.org/S77494981","display_name":"PEDIATRICS","issn_l":"0031-4005","issn":["0031-4005","1098-4275"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315734","host_organization_name":"American Academy of Pediatrics","host_organization_lineage":["https://openalex.org/P4310315734"],"host_organization_lineage_names":["American Academy of Pediatrics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatrics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070269405","display_name":"Joseph Biederman","orcid":"https://orcid.org/0000-0001-8233-663X","observed_orcids":["https://orcid.org/0000-0001-8233-663X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Biederman","raw_affiliation_strings":["Pediatric Psychopharmacology Department, Massachusetts General Hospital, Boston, Massachusetts","Pediatric Psychopharmacology Department, Massachusetts General Hospital, Boston, Massachusetts 02114, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Psychopharmacology Department, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Pediatric Psychopharmacology Department, Massachusetts General Hospital, Boston, Massachusetts 02114, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106236520","display_name":"Raun D. Melmed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raun D. Melmed","raw_affiliation_strings":["General Pediatrics, Melmed Center, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Pediatrics, Melmed Center, Scottsdale, Arizona","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anil Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anil Patel","raw_affiliation_strings":["Psychiatric Centers at San Diego, San Marcos, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Centers at San Diego, San Marcos, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068382742","display_name":"Keith McBurnett","orcid":"https://orcid.org/0000-0001-7327-2435","observed_orcids":["https://orcid.org/0000-0001-7327-2435"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith McBurnett","raw_affiliation_strings":["Department of Psychiatry, University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003395204","display_name":"Jennifer Konow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Konow","raw_affiliation_strings":["Late Phase Research, Kendle International Inc, Cincinnati, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Phase Research, Kendle International Inc, Cincinnati, Ohio","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrew Lyne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155342","display_name":"Shire (United Kingdom)","ror":"https://ror.org/0547dck29","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147578","https://openalex.org/I4387155342","https://openalex.org/I44892455"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Lyne","raw_affiliation_strings":["Shire Pharmaceutical Development Ltd, Basingstoke, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Pharmaceutical Development Ltd, Basingstoke, United Kingdom","institution_ids":["https://openalex.org/I4387155342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033482204","display_name":"Noreen Scherer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noreen Scherer","raw_affiliation_strings":["Shire Development, Inc, Wayne, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Development, Inc, Wayne, Pennsylvania","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the SPD503 Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"for the SPD503 Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.4342,"has_fulltext":false,"cited_by_count":323,"citation_normalized_percentile":{"value":0.9894201,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"121","issue":"1","first_page":"e73","last_page":"e84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/guanfacine-extended-release","display_name":"guanfacine extended release","score":0.9789999723434448},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.984000027179718},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.8980000019073486},{"id":"https://openalex.org/keywords/adhd-treatment-efficacy","display_name":"ADHD treatment efficacy","score":0.6499999761581421},{"id":"https://openalex.org/keywords/adhd-rating-scale","display_name":"ADHD Rating Scale","score":0.5580000281333923},{"id":"https://openalex.org/keywords/hyperactivity-impulsivity","display_name":"hyperactivity/impulsivity","score":0.8199999928474426},{"id":"https://openalex.org/keywords/inattention","display_name":"inattention","score":0.8659999966621399},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7409999966621399},{"id":"https://openalex.org/keywords/blood-pressure-changes","display_name":"blood pressure changes","score":0.6700000166893005},{"id":"https://openalex.org/keywords/alpha-2-adrenergic-agonists","display_name":"alpha-2 adrenergic agonists","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C2780815205","wikidata":"https://www.wikidata.org/wiki/Q5613599","display_name":"Guanfacine","level":3,"score":0.9550350904464722},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7861946821212769},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.7684102058410645},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7284656167030334},{"id":"https://openalex.org/C2780319597","wikidata":"https://www.wikidata.org/wiki/Q1549918","display_name":"Impulsivity","level":2,"score":0.6905020475387573},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.6870387196540833},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.6486841440200806},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.444215327501297},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4324207901954651},{"id":"https://openalex.org/C202061045","wikidata":"https://www.wikidata.org/wiki/Q7200267","display_name":"Placebo-controlled study","level":5,"score":0.41378432512283325},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.40925148129463196},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.34554338455200195},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25806206464767456},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.22307905554771423},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.19163933396339417},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.05993640422821045},{"id":"https://openalex.org/C2778399450","wikidata":"https://www.wikidata.org/wiki/Q412221","display_name":"Clonidine","level":2,"score":0.051575422286987305},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011336","descriptor_name":"Probability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016316","descriptor_name":"Guanfacine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1542/peds.2006-3695","doi":"https://doi.org/10.1542/peds.2006-3695","is_oa":false,"landing_page_url":"https://doi.org/10.1542/peds.2006-3695","pdf_url":null,"source":{"id":"https://openalex.org/S77494981","display_name":"PEDIATRICS","issn_l":"0031-4005","issn":["0031-4005","1098-4275"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315734","host_organization_name":"American Academy of Pediatrics","host_organization_lineage":["https://openalex.org/P4310315734"],"host_organization_lineage_names":["American Academy of Pediatrics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatrics","raw_type":"journal-article"},{"id":"pmid:18166547","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18166547","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatrics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W126876475","https://openalex.org/W1501686051","https://openalex.org/W1973930439","https://openalex.org/W1978755811","https://openalex.org/W1982166376","https://openalex.org/W2001510278","https://openalex.org/W2002691701","https://openalex.org/W2003848021","https://openalex.org/W2003858598","https://openalex.org/W2015106736","https://openalex.org/W2016483680","https://openalex.org/W2018897037","https://openalex.org/W2029643412","https://openalex.org/W2039755273","https://openalex.org/W2042702082","https://openalex.org/W2053548987","https://openalex.org/W2053758131","https://openalex.org/W2067292897","https://openalex.org/W2067355648","https://openalex.org/W2081653247","https://openalex.org/W2083338868","https://openalex.org/W2088839547","https://openalex.org/W2109089666","https://openalex.org/W2109935740","https://openalex.org/W2112484680","https://openalex.org/W2119599154","https://openalex.org/W2122518346","https://openalex.org/W2123980944","https://openalex.org/W2147123664","https://openalex.org/W2158377281","https://openalex.org/W2164549762","https://openalex.org/W2413440761","https://openalex.org/W2601578636","https://openalex.org/W2735404416","https://openalex.org/W3139845868","https://openalex.org/W4255249964","https://openalex.org/W4320288074"],"related_works":["https://openalex.org/W2022741651","https://openalex.org/W1849348377","https://openalex.org/W1991482221","https://openalex.org/W2063355126","https://openalex.org/W3016594565","https://openalex.org/W2157295589","https://openalex.org/W1992037783","https://openalex.org/W3090540231","https://openalex.org/W2108178511","https://openalex.org/W2010441791"],"abstract_inverted_index":{"OBJECTIVE:":[0],"With":[1],"this":[2,31],"study":[3],"we":[4],"assessed":[5],"the":[6,20,72,146,170,175,181,188,208,279],"efficacy":[7,283],"and":[8,24,97,178,204,228,253,264,281,290],"safety":[9],"of":[10,14,22,49,53,86,107,162,193,207,217],"an":[11],"extended-release":[12],"formulation":[13],"guanfacine":[15,54,119,165,196],"compared":[16,184,236,292],"with":[17,26,185,237,293],"placebo":[18,63,114,189],"for":[19,64],"treatment":[21,51,138],"children":[23,163,194],"adolescents":[25],"attention-deficit/hyperactivity":[27],"disorder.":[28],"METHODS:":[29],"In":[30],"multicenter,":[32],"double-blind,":[33],"placebo-controlled,":[34],"fixed-dosage":[35],"escalation":[36],"study,":[37],"patients":[38,109],"aged":[39],"6":[40],"to":[41,47,113,145,256],"17":[42],"years":[43],"were":[44,110,157,246,267,270],"randomly":[45,111],"assigned":[46,112],"1":[48],"3":[50,127],"groups":[52,161,192],"extended":[55,120,166,197,276],"release":[56,121,198,277],"(2,":[57],"3,":[58],"or":[59,62,118,132],"4":[60,133],"mg/day)":[61],"8":[65],"weeks.":[66],"The":[67,239],"primary":[68,280],"outcome":[69],"measurement":[70],"was":[71,287],"Attention-Deficit/Hyperactivity":[73,150,209],"Disorder":[74,151,210],"Rating":[75,93,100,152,211,224,231],"Scale":[76,153,212],"IV":[77,154],"total":[78,106,155],"score.":[79],"Secondary":[80],"measurements":[81],"included":[82],"Clinical":[83,214],"Global":[84,89,215,220],"Impression":[85,216],"Improvement,":[87,218],"Parent's":[88,219],"Assessment,":[90,221],"Conners'":[91,98,222,229],"Parent":[92,223],"Scale-Revised:":[94,101,225,232],"Short":[95,102,226,233],"Form,":[96,227],"Teacher":[99,230],"Form.":[103],"RESULTS:":[104],"A":[105],"345":[108],"(n":[115,124,129,135],"=":[116,125,130,136],"86)":[117,137],"2":[122],"mg":[123,128,134],"87),":[126],"86),":[131],"groups.":[139],"Least-squares":[140],"mean":[141],"changes":[142,258],"from":[143],"baseline":[144],"end":[147,284],"point":[148],"in":[149,159,169,174,180,187,259],"scores":[156],"significant":[158,200],"all":[160],"taking":[164,195],"release:":[167],"-16.18":[168],"2-mg":[171],"group,":[172,177,183],"-16.43":[173],"3-mg":[176],"-18.87":[179],"4-mg":[182],"-8.48":[186],"group.":[190],"All":[191],"showed":[199],"improvement":[201],"on":[202],"hyperactivity/impulsivity":[203],"inattentiveness":[205],"subscales":[206],"IV,":[213],"Form":[234],"assessments":[235],"placebo.":[238,294],"most":[240],"commonly":[241],"reported":[242],"treatment-emergent":[243],"adverse":[244],"events":[245],"headache,":[247],"somnolence,":[248],"fatigue,":[249],"upper":[250],"abdominal":[251],"pain,":[252],"sedation.":[254],"Small":[255],"modest":[257],"blood":[260],"pressure,":[261],"pulse":[262],"rate,":[263],"electrocardiogram":[265],"parameters":[266],"observed":[268],"but":[269],"not":[271],"clinically":[272],"meaningful.":[273],"CONCLUSIONS:":[274],"Guanfacine":[275],"met":[278],"secondary":[282],"points.":[285],"It":[286],"well":[288],"tolerated":[289],"effective":[291]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":39},{"year":2013,"cited_by_count":28},{"year":2012,"cited_by_count":28}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}